Posted in Daily
News 14 by admin on November, 18th 2012
Susan Walsh / AP
Food and Drug Administration (FDA) Commissioner Dr. Margaret Hamburg testified Wednesday, 14 November, 2012, before the House Energy subcommittee on oversight and investigations hearing about fungal meningitis outbreak. Without the legislation better, Hamburg, says more outbreaks can occur.
By Maggie Fox, NBC News
Food and Drug Administration officials know little about compounding pharmacies in the United States, including who all drugs and medical supplies, as they are made and where they are sent, the commissioner of the agency Thursday.
And, the FDA said Dr. Margaret Hamburg, it is possible that there might be another outbreak spread of fungal infections such as meningitis caused by contaminated injection pain that killed 32 people and sickened more than 460
Even with the re-examination showed pharmacy blamed for making and distributing a contaminated drug business with filthy conditions, and do not follow the rules, regulators at the FDA were arguing about how much they can really do to extinguish them, Hamburg said at a Senate hearing.
Hamburg and Dr. Lauren Smith, Interim Commissioner of the Massachusetts Department of Public Health, to face a day of testing at the Congress outbreak. The report by the House and Senate subcommittee holds a hearing to paint a picture of a mixed record, with some states, such as Tennessee and Colorado, working quickly and others, like Massachusetts, do a little. And they also pointed the finger at the FDA.
“While the quick work of the public health community has led to early detection and treatment of many cases of meningitis, and reduce deaths arising from contaminated methylprednisolone administration, committees of inquiry suggests that this crisis should have, and can, really avoid it,” Senate Health, Education , Labor and Pensions (HELP) Committee Report reads.
Continue Reading here
Susan Walsh / AP
Food and Drug Administration (FDA) Commissioner Dr. Margaret Hamburg testified Wednesday, 14 November, 2012, before the House Energy subcommittee on oversight and investigations hearing about fungal meningitis outbreak. Without the legislation better, Hamburg, says more outbreaks can occur.
By Maggie Fox, NBC News
Food and Drug Administration officials know little about compounding pharmacies in the United States, including who all drugs and medical supplies, as they are made and where they are sent, the commissioner of the agency Thursday.
And, the FDA said Dr. Margaret Hamburg, it is possible that there might be another outbreak spread of fungal infections such as meningitis caused by contaminated injection pain that killed 32 people and sickened more than 460
Even with the re-examination showed pharmacy blamed for making and distributing a contaminated drug business with filthy conditions, and do not follow the rules, regulators at the FDA were arguing about how much they can really do to extinguish them, Hamburg said at a Senate hearing.
Hamburg and Dr. Lauren Smith, Interim Commissioner of the Massachusetts Department of Public Health, to face a day of testing at the Congress outbreak. The report by the House and Senate subcommittee holds a hearing to paint a picture of a mixed record, with some states, such as Tennessee and Colorado, working quickly and others, like Massachusetts, do a little. And they also pointed the finger at the FDA.
“While the quick work of the public health community has led to early detection and treatment of many cases of meningitis, and reduce deaths arising from contaminated methylprednisolone administration, committees of inquiry suggests that this crisis should have, and can, really avoid it,” Senate Health, Education , Labor and Pensions (HELP) Committee Report reads.
Continue Reading here
No comments:
Post a Comment